MAPT and supranuclear palsy, progressive, 1: Several intronic pathogenic mutations in E10 disrupt or destabilize the highly self-complementary stem-loop to make this region more available for U1 snRNA, thereby increasing E10 inclusion and 4R-tau expression resulting in 4R tau dominant tauopathies, such as PSP and CBD [44].